Recruiting PHASE3 INTERVENTIONAL 2-arm NCT06020495

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia (DASSOH)

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia: a Multicenter Open-label Randomized Controlled Trial

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Hyponatremia

Interventions DDAVP Standard hyponatremia treatment

Updated 5 times since 2023 Last updated: May 20, 2025 Started: Dec 17, 2024 Primary completion: Sep 30, 2026 Completion: Nov 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06020495, this PHASE3 trial focuses on Hyponatremia and remains actively recruiting participants. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Recruiting PHASE3
Jan 2025 — Jun 2025 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE3
Sep 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Bobigny, France , Bondy, France , Colombes, France , Corbeil-Essonnes, France , Créteil, France , Dijon, France , La Roche-sur-Yon, France , Longjumeau, France , Paris, France and 2 more locations